{"DataElement":{"publicId":"7848489","version":"1","preferredName":"Liposome-encapsulated Daunorubicin-Cytarabine Administered Dose Modification Reason","preferredDefinition":"Information related to the cause of action to dose modification.","longName":"DS_MOD_RSN_CPX351","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7848484","version":"1","preferredName":"Liposome-encapsulated Daunorubicin-Cytarabine Administered","preferredDefinition":"A liposomal formulation containing a fixed combination of the antineoplastic agents cytarabine and daunorubicin in a 5:1 molar ratio. Liposome-encapsulated daunorubicin-cytarabine has been designed to provide optimal delivery of a specific ratio of cytarabine to daunorubicin, one that has been shown to be synergistic in vitro. The antimetabolite cytarabine competes with cytidine for incorporation into DNA, inhibiting DNA synthesis. This agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair. Daunorubicin, an intercalator and a topoisomerase II inhibitor, prevents DNA replication and inhibits protein synthesis. This agent also generates oxygen free radicals, resulting in the cytotoxic lipid peroxidation of cell membrane lipids._The act of having given something (e.g., a medication or test).","longName":"7848482v1.0:2233610v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"7848482","version":"1","preferredName":"Liposome-encapsulated Daunorubicin-Cytarabine","preferredDefinition":"A liposomal formulation containing a fixed combination of the antineoplastic agents cytarabine and daunorubicin in a 5:1 molar ratio. Liposome-encapsulated daunorubicin-cytarabine has been designed to provide optimal delivery of a specific ratio of cytarabine to daunorubicin, one that has been shown to be synergistic in vitro. The antimetabolite cytarabine competes with cytidine for incorporation into DNA, inhibiting DNA synthesis. This agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair. Daunorubicin, an intercalator and a topoisomerase II inhibitor, prevents DNA replication and inhibits protein synthesis. This agent also generates oxygen free radicals, resulting in the cytotoxic lipid peroxidation of cell membrane lipids.","longName":"C67504","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liposome-encapsulated Daunorubicin-Cytarabine","conceptCode":"C67504","definition":"A liposomal formulation containing a fixed combination of the antineoplastic agents cytarabine and daunorubicin in a 5:1 molar ratio. Liposome-encapsulated daunorubicin-cytarabine has been designed to provide optimal delivery of a specific ratio of cytarabine to daunorubicin, one that has been shown to be synergistic in vitro. The antimetabolite cytarabine competes with cytidine for incorporation into DNA, inhibiting DNA synthesis. This agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair. Daunorubicin, an intercalator and a topoisomerase II inhibitor, prevents DNA replication and inhibits protein synthesis. This agent also generates oxygen free radicals, resulting in the cytotoxic lipid peroxidation of cell membrane lipids.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"D27D9E6C-C615-0134-E053-4EBD850A878F","latestVersionIndicator":"Yes","beginDate":"2021-12-06","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-06","modifiedBy":"ONEDATA","dateModified":"2021-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008558","version":"1","preferredName":"Units of Measure","preferredDefinition":"the units of measure for assessment results and dosing.","longName":"UOM","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2DECB93-42CA-248A-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-28","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-28","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D27D9E6C-C623-0134-E053-4EBD850A878F","latestVersionIndicator":"Yes","beginDate":"2021-12-06","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-06","modifiedBy":"MAESKEB","dateModified":"2022-03-17","changeDescription":"AAML1831 -WL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6608518","version":"1","preferredName":"Dose Modification Reason","preferredDefinition":"Change, alteration, or adjustment of a dose specified in a treatment plan or/and administered to a patient._An explanation of the cause of some phenomenon or action.","longName":"6608518v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2757951","version":"1","preferredName":"Other","longName":"2757951","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4F52A8FB-E278-3426-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-06-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":"Added concept to value meaning. mc 3/20/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37E37E-1D77-1571-E053-F662850A3415","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Non-hematologic Toxicity","valueDescription":"Hematology Negation Toxicity","ValueMeaning":{"publicId":"6608519","version":"1","preferredName":"Hematology Negation Toxicity","longName":"6608519","preferredDefinition":"The branch of medicine that deals with the blood and blood-forming organs and the diseases thereof.: An operation in which a term denies or inverts the meaning of another term or construction.: The finding of bodily harm due to the poisonous effects of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematology","conceptCode":"C16673","definition":"The branch of medicine that deals with the blood and blood-forming organs and the diseases thereof.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F37E37E-1D85-1571-E053-F662850A3415","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37E37E-1DA0-1571-E053-F662850A3415","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Hematologic Toxicity","valueDescription":"Hematology Toxicity","ValueMeaning":{"publicId":"6608520","version":"1","preferredName":"Hematology Toxicity","longName":"6608520","preferredDefinition":"The branch of medicine that deals with the blood and blood-forming organs and the diseases thereof.: The finding of bodily harm due to the poisonous effects of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematology","conceptCode":"C16673","definition":"The branch of medicine that deals with the blood and blood-forming organs and the diseases thereof.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F37E37E-1DAD-1571-E053-F662850A3415","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7F37E37E-1DC6-1571-E053-F662850A3415","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"ONEDATA","dateModified":"2019-01-11","deletedIndicator":"No"},{"value":"Pulmonary","valueDescription":"Pulmonary","ValueMeaning":{"publicId":"3105402","version":"1","preferredName":"Pulmonary","longName":"3105402","preferredDefinition":"Relating to the lungs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pulmonary","conceptCode":"C13304","definition":"Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"88262FC2-D0D8-A44E-E040-BB89AD435306","latestVersionIndicator":"Yes","beginDate":"2010-06-03","endDate":null,"createdBy":"ALAIS","dateCreated":"2010-06-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B49150-2188-55B4-E053-4EBD850A3507","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","deletedIndicator":"No"},{"value":"Renal","valueDescription":"Renal","ValueMeaning":{"publicId":"2567551","version":"1","preferredName":"Renal","longName":"2567551","preferredDefinition":"Of or pertaining to the kidney.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Renal","conceptCode":"C25225","definition":"Of or pertaining to the kidney.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D4EC-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2003-12-19","modifiedBy":"CZECHS","dateModified":"2008-05-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B49150-2174-55B4-E053-4EBD850A3507","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","deletedIndicator":"No"},{"value":"Cardiac","valueDescription":"Cardiac","ValueMeaning":{"publicId":"2746220","version":"1","preferredName":"Cardiac","longName":"2746220","preferredDefinition":"Having to do with the heart.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cardiac","conceptCode":"C13306","definition":"Having to do with the heart.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4C175B6C-FDE7-2303-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":null,"endDate":null,"createdBy":"REEVESD","dateCreated":"2008-04-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B49150-217E-55B4-E053-4EBD850A3507","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","deletedIndicator":"No"},{"value":"GI/Hepatic","valueDescription":"GI/Hepatic","ValueMeaning":{"publicId":"7341664","version":"1","preferredName":"GI/Hepatic","longName":"7341664","preferredDefinition":"GI/Hepatic","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A8B49150-2192-55B4-E053-4EBD850A3507","latestVersionIndicator":"Yes","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B49150-21AB-55B4-E053-4EBD850A3507","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","deletedIndicator":"No"},{"value":"Infection","valueDescription":"Infection","ValueMeaning":{"publicId":"6610519","version":"1","preferredName":"Infection","longName":"6610519","preferredDefinition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Infection","conceptCode":"C128320","definition":"The invasion of an organism's body tissues by disease-causing agents and their multiplication, as well as the reaction by the host to these organisms and/or toxins that the organisms produce.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F7FD6EF-C887-4DB3-E053-F662850AB340","latestVersionIndicator":"Yes","beginDate":"2019-01-15","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-01-15","modifiedBy":"ONEDATA","dateModified":"2019-01-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B49150-21B5-55B4-E053-4EBD850A3507","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","deletedIndicator":"No"},{"value":"Myelosuppression","valueDescription":"Myelosuppression","ValueMeaning":{"publicId":"7117807","version":"1","preferredName":"Myelosuppression","longName":"7117807","preferredDefinition":"A laboratory test result indicating low production of erythrocytes, leukocytes and/or thrombocytes from the bone marrow.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Myelosuppression","conceptCode":"C9230","definition":"A laboratory test result indicating low production of erythrocytes, leukocytes and/or thrombocytes from the bone marrow.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9AF20906-BB37-5874-E053-F662850ADBD6","latestVersionIndicator":"Yes","beginDate":"2019-12-30","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-12-30","modifiedBy":"ONEDATA","dateModified":"2019-12-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A8B49150-21BF-55B4-E053-4EBD850A3507","beginDate":"2020-06-22","endDate":null,"createdBy":"GALITG","dateCreated":"2020-06-22","modifiedBy":"ONEDATA","dateModified":"2020-06-22","deletedIndicator":"No"},{"value":"Withdrawal of consent","valueDescription":"Withdrawal of Consent","ValueMeaning":{"publicId":"2573323","version":"1","preferredName":"Withdrawal of Consent","longName":"2573323","preferredDefinition":"Withdrawal of Consent","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EB78-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-02-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-02-22","modifiedBy":"REEVESD","dateModified":"2005-02-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D28060C2-6540-6C4A-E053-4EBD850AB116","beginDate":"2021-12-06","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-06","modifiedBy":"ONEDATA","dateModified":"2021-12-06","deletedIndicator":"No"},{"value":"Toxicity - specify","valueDescription":"Toxicity - specify","ValueMeaning":{"publicId":"7848490","version":"1","preferredName":"Toxicity - specify","longName":"7848490","preferredDefinition":"Toxicity - specify","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D28060C2-654A-6C4A-E053-4EBD850AB116","latestVersionIndicator":"Yes","beginDate":"2021-12-06","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-06","modifiedBy":"ONEDATA","dateModified":"2021-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D28060C2-6563-6C4A-E053-4EBD850AB116","beginDate":"2021-12-06","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-06","modifiedBy":"ONEDATA","dateModified":"2021-12-06","deletedIndicator":"No"},{"value":"Electrocardiogram QT corrected interval prolonged","valueDescription":"Electrocardiogram QT corrected interval prolonged","ValueMeaning":{"publicId":"6061690","version":"1","preferredName":"Electrocardiogram QT corrected interval prolonged","longName":"6061690","preferredDefinition":"A finding of a cardiac dysrhythmia characterized by an abnormally long corrected QT interval.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Electrocardiogram QT Corrected Interval Prolonged, CTCAE","conceptCode":"C143437","definition":"A finding of a cardiac dysrhythmia characterized by an abnormally long corrected QT interval.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"64821F28-F2B6-6579-E053-F662850AF3F1","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2018-02-05","modifiedBy":"HARTLEYG","dateModified":"2018-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2BB78CC-1CB2-01EB-E053-4EBD850A68CE","beginDate":"2021-12-09","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-09","modifiedBy":"ONEDATA","dateModified":"2021-12-09","deletedIndicator":"No"},{"value":"Hepatic toxicity","valueDescription":"Hepatic toxicity","ValueMeaning":{"publicId":"2578447","version":"1","preferredName":"Hepatic toxicity","longName":"2578447","preferredDefinition":"Hepatic toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF7C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"REEVESD","dateModified":"2006-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D2BB78CC-1CC6-01EB-E053-4EBD850A68CE","beginDate":"2021-12-09","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-09","modifiedBy":"ONEDATA","dateModified":"2021-12-09","deletedIndicator":"No"},{"value":"SOS/VOD","valueDescription":"SOS/VOD","ValueMeaning":{"publicId":"8119875","version":"1","preferredName":"SOS/VOD","longName":"8119875","preferredDefinition":"SOS/VOD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB0A7F5B-4081-4B45-E053-4EBD850AEF5E","latestVersionIndicator":"Yes","beginDate":"2022-03-25","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-25","modifiedBy":"ONEDATA","dateModified":"2022-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB0A7F5B-409A-4B45-E053-4EBD850AEF5E","beginDate":"2022-03-25","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-25","modifiedBy":"ONEDATA","dateModified":"2022-03-25","deletedIndicator":"No"},{"value":"Hepatic toxicity (not SOS)","valueDescription":"Hepatic toxicity (not SOS)","ValueMeaning":{"publicId":"8119876","version":"1","preferredName":"Hepatic toxicity (not SOS)","longName":"8119876","preferredDefinition":"Hepatic toxicity (not SOS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DB0A7F5B-40A4-4B45-E053-4EBD850AEF5E","latestVersionIndicator":"Yes","beginDate":"2022-03-25","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-25","modifiedBy":"ONEDATA","dateModified":"2022-03-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DB0A7F5B-40BD-4B45-E053-4EBD850AEF5E","beginDate":"2022-03-25","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-25","modifiedBy":"ONEDATA","dateModified":"2022-03-25","deletedIndicator":"No"},{"value":"Rash","valueDescription":"RASH","ValueMeaning":{"publicId":"2561333","version":"1","preferredName":"RASH","longName":"2561333v1.00","preferredDefinition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Skin Rash","conceptCode":"C39594","definition":"Any change in the skin which affects its appearance or texture. A rash may be localized to one part of the body, or affect all the skin. Rashes may cause the skin to change color, itch, become warm, bumpy, dry, cracked or blistered, swell and may be painful.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-BCA2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-05-22","endDate":null,"createdBy":"PWEST","dateCreated":"2002-05-22","modifiedBy":"KUMMEROA","dateModified":"2023-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DAFE6120-8FF7-7B03-E053-4EBD850A1474","beginDate":"2022-03-24","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-24","modifiedBy":"ONEDATA","dateModified":"2022-03-24","deletedIndicator":"No"},{"value":"Allergy","valueDescription":"Allergy","ValueMeaning":{"publicId":"2570084","version":"1","preferredName":"Allergy","longName":"2570084v1.00","preferredDefinition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Allergic Reaction","conceptCode":"C114476","definition":"An immune response that occurs following re-exposure to an innocuous antigen, and that requires the presence of existing antibodies against that antigen. This response involves the binding of IgE to mast cells, and may worsen with repeated exposures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-DED1-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-06-21","endDate":null,"createdBy":"SBR","dateCreated":"2004-06-21","modifiedBy":"CLOHNES","dateModified":"2023-05-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DAFE6120-9001-7B03-E053-4EBD850A1474","beginDate":"2022-03-24","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-24","modifiedBy":"ONEDATA","dateModified":"2022-03-24","deletedIndicator":"No"},{"value":"Neurological Toxicity","valueDescription":"Neurological Toxicity","ValueMeaning":{"publicId":"8119815","version":"1","preferredName":"Neurological Toxicity","longName":"8119815","preferredDefinition":"Neurological Toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DAFE6120-900B-7B03-E053-4EBD850A1474","latestVersionIndicator":"Yes","beginDate":"2022-03-24","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-24","modifiedBy":"ONEDATA","dateModified":"2022-03-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DAFE6120-9024-7B03-E053-4EBD850A1474","beginDate":"2022-03-24","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-24","modifiedBy":"ONEDATA","dateModified":"2022-03-24","deletedIndicator":"No"},{"value":"Renal Toxicity","valueDescription":"Renal toxicity","ValueMeaning":{"publicId":"2571819","version":"1","preferredName":"Renal toxicity","longName":"2571819","preferredDefinition":"Renal toxicity","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E598-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-08","modifiedBy":"CAMPBELB","dateModified":"2004-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DAFE6120-902E-7B03-E053-4EBD850A1474","beginDate":"2022-03-24","endDate":null,"createdBy":"LEEW","dateCreated":"2022-03-24","modifiedBy":"ONEDATA","dateModified":"2022-03-24","deletedIndicator":"No"},{"value":"Hematologic toxicity","valueDescription":"Hematologic Toxicity","ValueMeaning":{"publicId":"2871566","version":"1","preferredName":"Hematologic Toxicity","longName":"2871566","preferredDefinition":"Pertaining to or related to the blood and blood-forming organs.: Toxicity; the degree to which something is poisonous.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematologic","conceptCode":"C62780","definition":"Pertaining to or related to the blood and blood-forming organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Toxicity","conceptCode":"C27990","definition":"The finding of bodily harm due to the poisonous effects of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6943FAAB-DDC4-2A41-E040-BB89AD4327F0","latestVersionIndicator":"Yes","beginDate":"2009-05-06","endDate":null,"createdBy":"MAESKEB","dateCreated":"2009-05-06","modifiedBy":"ONEDATA","dateModified":"2009-05-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DBFE5713-5CF5-3509-E053-4EBD850A3C25","beginDate":"2022-04-06","endDate":null,"createdBy":"LEEW","dateCreated":"2022-04-06","modifiedBy":"ONEDATA","dateModified":"2022-04-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008517","version":"1","preferredName":"Adverse Events","preferredDefinition":"any unfavorable symptoms, signs, or disease temporally associated with the use of a medical\r\ntreatment or procedure that may or may not be considered related to the medical\r\ntreatment or procedure.","longName":"AE","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AB51E03C-635E-5672-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-09-23","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-09-23","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":"Definition copied from CTC Manual.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4330811","version":"1","preferredName":"Dose Modification Reason","preferredDefinition":"Change, alteration, or adjustment of a dose specified in a treatment plan or/and administered to a patient.:An explanation of the cause of some phenomenon or action.","longName":"C54346:C25638","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Dose Modification","conceptCode":"C54346","definition":"Change, alteration, or adjustment of a dose specified in a treatment plan or/and administered to a patient.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Reason","conceptCode":"C25638","definition":"An explanation of the cause of some phenomenon or action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9F00373-112F-6F5B-E040-BB89AD436CC0","latestVersionIndicator":"Yes","beginDate":"2014-05-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-05-21","modifiedBy":"ONEDATA","dateModified":"2014-05-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F37E37E-1D62-1571-E053-F662850A3415","latestVersionIndicator":"Yes","beginDate":"2019-01-11","endDate":null,"createdBy":"PROSVIROVAB","dateCreated":"2019-01-11","modifiedBy":"LEEW","dateModified":"2022-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Dose modification reason:","type":"Preferred Question Text","description":"Dose modification reason:","url":null,"context":"COG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D27FA406-F5DD-6F74-E053-4EBD850A6814","latestVersionIndicator":"Yes","beginDate":"2021-12-06","endDate":null,"createdBy":"LEEW","dateCreated":"2021-12-06","modifiedBy":"LEEW","dateModified":"2022-01-10","changeDescription":"AAM1831-WL","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}